116 related articles for article (PubMed ID: 24790054)
1. Are there any new pharmacologic therapies on the horizon to better treat hypertension? A state-of-the-art paper.
Habib GB; Basra SS
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):516-25. PubMed ID: 24790054
[TBL] [Abstract][Full Text] [Related]
2. Clinical role of direct renin inhibition in hypertension.
Taylor AA; Pool JL
Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
[TBL] [Abstract][Full Text] [Related]
3. New approaches in the treatment of hypertension.
Oparil S; Schmieder RE
Circ Res; 2015 Mar; 116(6):1074-95. PubMed ID: 25767291
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
5. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
6. Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand?
Chen SS; Seliger SL; Fried LF
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):449-55. PubMed ID: 25014549
[TBL] [Abstract][Full Text] [Related]
7. Direct renin inhibitors as antihypertensive agents.
Israili ZH; Velasco M; Bermúdez V
Am J Ther; 2010; 17(3):237-54. PubMed ID: 20479579
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
[TBL] [Abstract][Full Text] [Related]
9. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
10. A rationale for treatment of endothelial dysfunction in hypertension.
Ruschitzka F; Corti R; Noll G; Lüscher TF
J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
[TBL] [Abstract][Full Text] [Related]
11. Peptides as targets for antihypertensive drug development.
Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
[TBL] [Abstract][Full Text] [Related]
12. Hypertension management in an outpatient clinic at the Institute of Cardiology of Abidjan (Ivory Coast).
Kramoh EK; N'goran YN; Aké-Traboulsi E; Anzouan-Kacou JB; Konin CK; Coulibaly I; Traoré F; Agbechi YM; Guikahue MK
Arch Cardiovasc Dis; 2011 Nov; 104(11):558-64. PubMed ID: 22117907
[TBL] [Abstract][Full Text] [Related]
13. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive therapy in the presence of proteinuria.
Sarafidis PA; Khosla N; Bakris GL
Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
[TBL] [Abstract][Full Text] [Related]
15. A global approach to hypertension.
van den Meiracker AH
EuroIntervention; 2013 May; 9 Suppl R():R16-20. PubMed ID: 23732150
[TBL] [Abstract][Full Text] [Related]
16. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
17. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
[TBL] [Abstract][Full Text] [Related]
18. New drug targets for hypertension: A literature review.
Gao Q; Xu L; Cai J
Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166037. PubMed ID: 33309796
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
[TBL] [Abstract][Full Text] [Related]
20. Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice.
Volpe M; Tocci G
Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):811-20. PubMed ID: 20528639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
